Rocket Lab Corporation (NASDAQ:RKLB) experienced a turbulent first day as a Nasdaq-100 component, with shares sliding approximately 7.2% to $99.49 in afternoon trading on Monday. The decline occurred despite the anticipated passive inflows from index-tracking funds, as the stock faced headwinds from a newly disclosed at-the-market equity offering program and a widespread selloff in the space sector.
Index Inclusion and Market Dynamics
Rocket Lab joined the Nasdaq-100 index alongside Astera Labs, CoreWeave, Nebius, and Teradyne ahead of Monday's open. The index is tracked by over 200 investment products with more than $800 billion in assets under management, typically forcing passive funds to acquire shares of newly added companies. However, this mechanical buying was insufficient to counteract other pressures.
The stock hit an intraday high of $107.37 before falling to a low of $96.56, with more than 18.8 million shares changing hands by early afternoon. The volatility reflected the complex interplay between index-driven demand and company-specific risks.
Dilution Concerns from ATM Program
A key factor weighing on the stock is Rocket Lab's at-the-market (ATM) equity offering program, which allows the company to sell up to $3 billion in common stock directly into the market at prevailing prices. A May prospectus also authorizes forward-sale arrangements, where bank counterparties can borrow and sell shares to hedge their exposure. Rocket Lab has acknowledged that such hedge sales could depress the stock price or limit upside.
This program creates a dual dynamic: while index inclusion brings new buyers, it also provides a liquid channel for the company and its banking partners to offload shares. The net effect on Monday was decidedly negative, as the market focused on potential dilution.
Space Sector Contagion
Rocket Lab's decline was part of a broader rout in space-related equities. SpaceX dropped 10.4%, Firefly Aerospace slid 6.1%, and Redwire fell 9.1%. The sector-wide weakness amplified the selling pressure on Rocket Lab, making its Nasdaq-100 debut appear less like a standalone event and more like a reflection of shifting investor sentiment toward the industry.
Analysts at KeyBanc had recently described the SpaceX-driven selloff as "unwarranted," calling Rocket Lab the "clear #2 to SpaceX" and highlighting strong demand for satellites, launch services, and the company's $2.2 billion contract backlog. However, the market did not embrace that view on Monday.
Fundamentals and Outlook
Despite the stock's weakness, Rocket Lab's underlying business continues to show robust growth. First-quarter revenue reached $200.3 million, up 63.5% year-over-year, with gross margin improving to 38.2%. The company ended the quarter with a record backlog of $2.2 billion. For the second quarter, management guided for revenue between $225 million and $240 million.
The medium-lift Neutron rocket remains on track for its debut launch later this year, a milestone that could significantly expand Rocket Lab's addressable market. CEO Sir Peter Beck characterized the Nasdaq-100 inclusion as a "landmark moment," signaling the company's evolution from a small player to a global space leader.
Risk Factors
Rocket Lab remains unprofitable on a GAAP basis, reporting a first-quarter net loss of $45.0 million. The company's valuation could come under pressure if Neutron's development faces delays, launch cadence slows, or the company taps its ATM program for additional capital. While such a move would strengthen the balance sheet, it would also dilute existing shareholders against a relatively narrow earnings base.
As the week progresses, market participants will watch whether index inclusion leads to a more permanent shift in Rocket Lab's shareholder base. For now, the stock's first day in the Nasdaq-100 has been marked by selling rather than celebration.
